IACS-1131

N/A

Report date: 2026/02/27 10:57:04
NME

Base Information

Drug NameIACS-1131
Drug Alias NameIACS-1131IACS1131
ClassificationSmall molecules
Mechanisms of ActionMitochondrial complex I (NADH dehydrogenase) inhibitors
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A